| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |